Company
Headquarters: Las Vegas, NV, United States
CEO: Dr. Edward E. Jacobs Jr.
$655,749
USD as of July 1, 2023
| Company | Market Cap (USD) |
|---|---|
| Walmart | $428.87 B |
| Procter & Gamble | $350.35 B |
| Kweichow Moutai | $299.54 B |
| Costco | $287.69 B |
| L'Oréal | $262.20 B |
BioAdaptives, Inc. operates as a research, development, and educational company. The company focuses on offering health and wellness products, such as dietary supplements and specialty food items for humans and animals. It offers PrimiCell, PrimiLungs, and PluriPain or humans; and Canine Regen and Equine Regen for dogs and horses. The company was formerly known as APEX 8 Inc. and changed its name to BioAdaptives, Inc. in September 2013. BioAdaptives, Inc. was incorporated in 2013 and is based in Las Vegas, Nevada.
Top 1-year algo backtest: +269.94%
$10,000 in May 2023 would now be $36,994 by following this algorithm daily at market close.
Boost your stocks returns with Disfold AI... Now!
Try Disfold AI for FREE
Bioadaptives, Inc. has the following listings and related stock indices.
Stock: OTC: BDPT wb_incandescent